跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 316 条关于
“kallikrein B1”
全部
316
临床试验
153
药物
64
机构
3
资讯
96
去年
Intellia's NTLA-2002 Shows Promise in Phase II Trial for Hereditary Angioedema
去年
Intellia's NTLA-2002 Shows Promise in Phase II Trial for Hereditary Angioedema
去年
CRISPR Therapy NTLA-2002 Shows Promise in Hereditary Angioedema Treatment
去年
Intellia's CRISPR Gene Therapy Shows 98% Reduction in HAE Attacks After Three Years
2年前
Intellia's CRISPR Gene Therapy Shows Potential as Functional Cure for Hereditary Angioedema in Long-Term Study
9个月前
Zetagen Therapeutics Raises $12.9M in Oversubscribed Series B1 Round Following Promising Phase 2a Results for Breast Cancer Treatment
去年
Triveni Bio Initiates First-in-Human Trial of TRIV-509 for Atopic Dermatitis, Targeting Novel Kallikrein Pathway
去年
Clinical Trial Explores Vitamin B1's Potential in Early Alzheimer's Treatment
去年
UPMC Enterprises Leads $18.25 Million Series B1 Investment in Carta Healthcare for AI-Powered Clinical Data Management
去年
Rezolute's Oral Plasma Kallikrein Inhibitor RZ-402 Shows Promise in Phase IIa Trial for Diabetic Macular Edema
第 1 页,共 10 页
上一页
下一页